President's Obama's Dec. 13 signing of the 21st Century Cures Act has opened the door for FDA to break its silence on the law, with top agency regulators giving their blessing to the legislation – at least to some extent.
Woodcock, Califf Give Thumbs Up To Certain 21st Century Cures Provisions
US regulators offer their support for law's hiring provisions, limited population pathway for antimicrobials, and patient-focused drug development aspects; but remain mum on the funding levels.